Susquehanna International Group’s Cogent Biosciences COGT Stock Holding History

Susquehanna International Group’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.8M	Sell	279,900 -36,900	-12%	-$1.36M	﹤0.01%	3009
2025 Q4	$11.3M	Buy	316,800 +45,800	+17%	+$1.29M	﹤0.01%	2901
2025 Q3	$3.89M	Buy	271,000 +168,500	+164%	+$2M	﹤0.01%	4518
2025 Q2	$736K	Buy	+102,500	New	+$568K	﹤0.01%	8225
2025 Q1	–	Sell	-100,900	Closed	-$787K	–	12587
2024 Q4	$787K	Buy	100,900 +86,800	+616%	+$865K	﹤0.01%	7552
2024 Q3	$152K	Sell	14,100 -11,300	-44%	-$110K	﹤0.01%	10725
2024 Q2	$214K	Buy	25,400 +1,200	+5%	+$9.1K	﹤0.01%	10209
2024 Q1	$163K	Buy	+24,200	New	+$150K	﹤0.01%	10828
2023 Q4	–	Sell	-15,000	Closed	-$146K	–	12454
2023 Q3	$146K	Buy	+15,000	New	+$178K	﹤0.01%	10565
2022 Q3	–	Sell	-22,100	Closed	-$199K	–	13270
2022 Q2	$199K	Buy	+22,100	New	+$151K	﹤0.01%	10640

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Susquehanna International Group's COGT Position: Q1 2026 in Review

Susquehanna International Group reduced its Cogent Biosciences (COGT) stake by 75% in Q1 2026, selling an estimated $7.87M and leaving 70,478 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #5486.

Susquehanna International Group first reported a position in COGT in Q3 2018 and has held it in 19 quarters since. The position peaked at $10.1M in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

Susquehanna International Group held 70,478 shares of Cogent Biosciences worth $2.71M as of Q1 2026.
Susquehanna International Group sold 213,019 Cogent Biosciences shares in Q1 2026, an estimated $7.87M.
Cogent Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5486 holding.
Susquehanna International Group first reported a position in Cogent Biosciences in Q3 2018 and has held it in 19 quarters since.
Susquehanna International Group's Cogent Biosciences position peaked at $10.1M in Q4 2025.
305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.